benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel
- RxCUI
- 1540241
- RxNorm name
- benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel
- Display name
- Benzoyl peroxide/Clindamycin (Topical)
- Full name
- benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel
- Term type
- SCD
- Status
- Active
- Strength
- 5-1.2%
- Dose form
- Gel
- Route
- Topical
- Updated
- 2026-09-29 04:11:54
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072014
- Active start
- 072014
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| benzoyl peroxide | 0.05 MG / 1 MG | benzoyl peroxide | benzoyl peroxide |
| clindamycin phosphate | 0.012 MG / 1 MG | clindamycin | clindamycin phosphate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Gel | 346286 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| benzoyl peroxide | 1418 |
| clindamycin | 2582 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel | 1 | NAMES |
| RxNorm Name | benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel | 1 | NAMES |
| RxNorm Synonym | benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 5 | CODES | |
| RxCUI | 1540241 | 1 | CODES |
| MMSL_CODE | 3 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 21922-022-06 | 21922-022 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Encube Ethicals, Inc. | ANDA212433 |
| 45802-736-84 | 45802-736 | clindamycin phosphate and benzoyl peroxide Clindamycin, Benzoyl Peroxide | Padagis Israel Pharmaceuticals Ltd | ANDA090979 |
| 51672-1366-6 | 51672-1366 | Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | ANDA206218 |
| 70710-1445-4 | 70710-1445 | Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide | Zydus Pharmaceuticals USA Inc. | ANDA210794 |
| 71335-2878-1 | 71335-2878 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bryant Ranch Prepack | ANDA212433 |
| 72162-2299-2 | 72162-2299 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bryant Ranch Prepack | ANDA212433 |
| 72603-322-01 | 72603-322 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Northstar Rx LLC | ANDA212433 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA212433 | 21922-022 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | ANDA | Encube Ethicals, Inc. |
| ANDA090979 | 45802-736 | clindamycin phosphate and benzoyl peroxide Clindamycin, Benzoyl Peroxide | ANDA | Padagis Israel Pharmaceuticals Ltd |
| ANDA206218 | 51672-1366 | Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide | ANDA | Sun Pharmaceutical Industries, Inc. |
| ANDA210794 | 70710-1445 | Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide | ANDA | Zydus Pharmaceuticals USA Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| abede379-52d1-4000-ae38-cc99f88fe3b2 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY] | 3 | 101 | These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 2000 | 20240430 |
| be216018-c30d-4184-9152-ae238e3edac4 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY] | 3 | 100 | These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 2000 | 20251022 |
| 1c7040f2-e503-408a-b07e-72c7972ce78d | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY] | 3 | 8 | These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL. CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE gel, for topical use Initial U.S. Approval: 2000 | 20230726 |
| e2cd1c2a-00ee-465e-a4f4-9c0a0bc6266f | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY] | 3 | 3 | These highlights do not include all the information needed to use Neuac ® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/5% safely and effectively. See full prescribing information for Neuac ® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/5%. Neuac ® (CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE) gel, for topical use. Initial U.S. Approval: 2000 | 20231115 |
| 8ca01174-431e-449a-a85e-8c68d506776c | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY] | 3 | 2 | These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 2000 | 20250829 |
| 83d52507-99a1-4461-b067-5ec01dc6c5d3 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel [PSN] · benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [SCD] · benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel [SY] | 3 | 2 | These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL. CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE gel, 1.2%/5%, for topical use Initial U.S. Approval: 2000 | 20221005 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| be216018-c30d-4184-9152-ae238e3edac4 | These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20251022 |
| 8ca01174-431e-449a-a85e-8c68d506776c | These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 2000 | Encube Ethicals, Inc. | Encube Ethicals Private Limited | 20250829 |
| b39aaacb-f429-4cb4-b88b-341b8b8b217c | These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL. CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE gel, 1.2%/5%, for topical use Initial U.S. Approval: 2000 | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 20250703 |
| 2fcf4e8d-dd05-49c2-948b-10abbb52e4bc | Rx Only These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL, 1.2% / 5% for topical use Initial U.S. Approval: 2000 | Northstar Rx LLC | Encube Ethicals Private Limited | 20241108 |
| abede379-52d1-4000-ae38-cc99f88fe3b2 | These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2% / 5%, for topical use Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20240430 |
| 60fb2e2f-e1a2-464a-9c9f-52a5d5ca5acc | These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL, 1.2% / 5% safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL, 1.2% / 5%. CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL, 1.2% / 5% for topical use Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20240111 |
| 1c7040f2-e503-408a-b07e-72c7972ce78d | These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE GEL. CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE gel, for topical use Initial U.S. Approval: 2000 | Padagis Israel Pharmaceuticals Ltd | 20230726 |
| 83d52507-99a1-4461-b067-5ec01dc6c5d3 | These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL. CLINDAMYCIN PHOSPHATE and BENZOYL PEROXIDE gel, 1.2%/5%, for topical use Initial U.S. Approval: 2000 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20221005 |
| 436141cb-5ee3-4478-a5e2-ba2a7264ea4b | These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL, 1.2% / 5% safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL, 1.2% / 5%. CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL, 1.2% / 5% for topical use Initial U.S. Approval: 2000 | Sandoz Inc. | 20191030 |
| 23b5c29b-4b63-49e3-80c2-902a9d1bc411 | These highlights do not include all the information needed to use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% safely and effectively. See full prescribing information for Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%. Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% For topical use Initial U.S. Approval: 2000 | Prasco Laboratories | 20150415 |
| 272617e6-1840-441d-abc8-40518d20c44a | National Council for Prescription Drug Programs | 20130213 | |
| 94e3ec69-f1e3-422c-94e5-c1d13c418b1d | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G01AA | Antibiotics | ATC1-4 | clindamycin | |
| ATC | D10AF | Antiinfectives for treatment of acne | ATC1-4 | clindamycin | |
| ATC | J01FF | Lincosamides | ATC1-4 | clindamycin | |
| ATC | D10AE | Peroxides | ATC1-4 | benzoyl peroxide | |
| FDASPL | D055231 | Lincosamides | CHEM | has_chemical_structure | clindamycin |
| FDASPL | N0000175443 | Lincosamide Antibacterial | EPC | has_epc | clindamycin |
| FDASPL | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | clindamycin |
| FDASPL | N0000175731 | Neuromuscular Blockade | PE | has_pe | clindamycin |
| MEDRT | D001585 | Benzoyl Peroxide | CHEM | has_ingredient | benzoyl peroxide |
| MEDRT | D002981 | Clindamycin | CHEM | has_ingredient | clindamycin |
| MEDRT | D002981 | Clindamycin | CHEM | has_ingredient | clindamycin phosphate |
| MEDRT | D008034 | Lincomycin | CHEM | ci_chemclass | clindamycin |
| MEDRT | D008034 | Lincomycin | CHEM | ci_chemclass | clindamycin phosphate |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | benzoyl peroxide |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | clindamycin |
| MEDRT | D000193 | Actinomycetales Infections | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | D000193 | Actinomycetales Infections | DISEASE | may_treat | clindamycin |
| MEDRT | D001442 | Bacteroides Infections | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | D001442 | Bacteroides Infections | DISEASE | may_treat | clindamycin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | clindamycin phosphate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzoyl peroxide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | clindamycin |
| MEDRT | D004697 | Endocarditis, Bacterial | DISEASE | may_prevent | clindamycin phosphate |
| MEDRT | D004697 | Endocarditis, Bacterial | DISEASE | may_prevent | clindamycin |
| MEDRT | D004761 | Enterocolitis, Pseudomembranous | DISEASE | ci_with | clindamycin phosphate |
| MEDRT | D004761 | Enterocolitis, Pseudomembranous | DISEASE | ci_with | clindamycin |
| MEDRT | D017093 | Liver Failure | DISEASE | ci_with | clindamycin |
| MEDRT | D017093 | Liver Failure | DISEASE | ci_with | clindamycin phosphate |
| MEDRT | D011020 | Pneumonia, Pneumocystis | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | D011020 | Pneumonia, Pneumocystis | DISEASE | may_treat | clindamycin |
| MEDRT | D012393 | Rosacea | DISEASE | may_treat | benzoyl peroxide |
| MEDRT | D013203 | Staphylococcal Infections | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | D013203 | Staphylococcal Infections | DISEASE | may_treat | clindamycin |
| MEDRT | D013290 | Streptococcal Infections | DISEASE | may_treat | clindamycin |
| MEDRT | D013290 | Streptococcal Infections | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | D014123 | Toxoplasmosis | DISEASE | may_treat | clindamycin |
| MEDRT | D014123 | Toxoplasmosis | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | D016585 | Vaginosis, Bacterial | DISEASE | may_treat | clindamycin |
| MEDRT | D016585 | Vaginosis, Bacterial | DISEASE | may_treat | clindamycin phosphate |
| MEDRT | N0000000170 | Free Radical Scavenging Activity | MOA | has_moa | benzoyl peroxide |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | clindamycin |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | clindamycin phosphate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | clindamycin |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | clindamycin phosphate |
| MEDRT | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | benzoyl peroxide |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.05 MG/MG / 0.012 MG/MG (expressed as clindamycin phosphate) |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA090979 |
| CODES | ANDA | ANDA210794 |
| CODES | ANDA | ANDA212433 |
| CODES | VUID | 4032019 |
| NAMES | Prescribable Synonym | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |